The respective indications for heparin and oral anticoagulants reflect their respective advantages and disadvantages for the. Occasionally, anticoagulation is also indicated in pregnant women with valvular or congenital heart disease. Apr 21, 20 anticoagulants remain the primary strategy for the prevention and treatment of thrombosis. Guidelines for use of anticoagulation in pregnancy.
Safety of anticoagulants in pregnancy and breastfeeding. Anticoagulation during pregnancy ash clinical news. The risk further increases if an underlying thrombophilia is present. Fortunately, lowmolecularweight heparins lmwhs and unfractionated heparin are quite safe and efficacious when properly selected, dosed, and monitored. Congestion within the pelvic veins from a gravid uterus leads to decreased blood flow to the lower extremities, and compression of the left iliac vein by the right iliac artery is a wellknown phenomenon. Anticoagulants and antiplatelet drugs eliminate or reduce the risk of blood clots. Directacting oral anticoagulants doacs in pregnancy. Although warfarin is contraindi possible side effects and complications of therapy to cated during pregnancy, it is not contraindicated manage anticoagulants safely in pregnancy. To reduce the incidence of vte in pregnancy, and improve outcomes, a wider understanding of the risk factors involved and a better identification of women at risk of thrombosis coupled with effective thromboprophylaxis and treatment of vte are required. The choice of an anticoagulant requires consideration of maternal risks, potential for teratogenicity, the underlying condition necessitating the treatment, and cost. Some pregnant women require anticoagulation during pregnancy andor in. Although aspirin crosses the placenta, it is safe in low doses. Thrombosis task force 1990 guidelines on oral anticoagulation.
Get a printable copy pdf file of the complete article 925k, or click on a page image below to browse page by page. Use of anticoagulants during pregnancy is challenging due to the potential teratogenic effects and dosing complexities of the various agents, and the management of anticoagulation around the time of labor. Pharmacists letter includes 12 issues every year, with brief articles about new meds and hot topics. The choice of appropriate anticoagulant depends on the stage of pregnancy. This is not the case when the pregnant women has a native valvulopathy in atrial fibrillation, a mechanical prosthesis or a coagulation anomaly. For example, vitamin k antagonists are the most efficacious for preventing mechanical valve thrombosis, but they pose risks to the fetus. Anticoagulants are medicines that keep your blood from clotting, or turning into solid clumps of cells that stick together. Anticoagulants remain the primary strategy for the prevention and treatment of thrombosis. Because of the risks to both mother and baby, this is a doubly challenging patient population for the delivery of safe, effective anticoagulation. Unfortunately, as discussed above, the use of these agents during pregnancy carries a risk of teratogenicity and toxic fetal effects and increases the risk of pregnancy loss and maternal hemorrhage. Maternal and fetal concerns must be considered at all times, with a careful assessment of the risks and benefits of anticoagulant therapy in each patient. Drugs used to treat anticoagulation during pregnancy the following list of medications are in some way related to, or used in the treatment of this condition. The role of anticoagulants in the prevention of pregnancy.
A subset of pregnant patients requires anticoagulation during pregnancy andor in the postpartum period, including women at high risk of deep vein thrombosis and women with prosthetic heart valves, atrial fibrillation, cerebral venous sinus thrombosis, left ventricular dysfunction, and some women with fetal loss. Many of the available anticoagulant agents may be used safely in pregnancy, but they are disadvantaged by competing efficacy and risks to the mother and fetus. Category c the existence of risks cannot be ruled out. Fda classification of drugs for use in pregnancy and breastfeeding fda classification according to risk in pregnancy category a no apparent risks. All major evidencebased guidelines recommend lmwh as the preferred anticoagulant for pregnant women. Pregnancy is a hypercoagulable state that increases the risk of thromboembolic events. Current status of anticoagulation in pregnancy the risks associated with oral anticoagulants occur primarily during the second part of the. Choosing anticoagulant therapies during pregnancy involves a balance of risks and benefits to both the mother and fetus.
Anticoagulation in pregnant women with artificial heart valves. Thrombophilias have been associated with both maternal and fetal. In addition, women receiving chronic anticoagulation who are contemplating pregnancy need counseling regarding how to avoid the potential. These guidelines focus on the optimal management of anticoagulant drugs for the prevention and treatment of vte following the choice of an anticoagulant. Multiple changes occur to the coagulation system as pregnancy progresses, with the largest changes being seen at term gestation. Use of anticoagulants during pregnancy and postpartum.
Women requiring anticoagulation need careful attention throughout pregnancy and the postpartum period. Its worth noting that while evidencebased guideline recommendations for anticoagulation in pregnancy have been published, they are based primarily on observational studies and extrapolation of data from nonpregnant patients. However, the safety of higher doses of aspirin during the first pregnancy is uncertain. The choice of anticoagulant therapy, the degree of monitoring, and the therapeutic target should be modulated by balancing the risks and the benefits to the mother and fetus. Anticoagulants may be indicated during pregnancy for the treatment or prophylaxis of venous thromboembolism and, in patients with mechanical prosthetic cardiac valves, for the prevention of valve thrombosis and systemic embolisation. Our practices are largely consistent with guidelines from societies. Unfractionated heparin, low molecular weight heparin, fondaparinux, and warfarin have. Management of anticoagulants during pregnancy heart.
Get concise advice on drug therapy, plus unlimited access to ce. Ginsberg and others published use of anticoagulants during pregnancy find, read and cite all the research you need on researchgate. Many of the available anticoagulant agents may be used safely. Several newer anticoagulants can be used in pregnancy table 3. May 10, 2019 we aimed to perform an analysis of individual case safety reports retrieved after the standardized meddra query pregnancy and neonatal topics for which directacting oral anticoagulants. Use of anticoagulants during pregnancy and postpartum uptodate. Pdf anticoagulants in pregnancy leo brancazio academia. May 03, 20 new anticoagulants such as direct factor xa inhibitors and direct thrombin inhibitors have been recently developed, but their experience in pregnancy is limited. Anticoagulation for pregnant women with acute deep vein thrombosis dvt or pulmonary embolism pe 5.
May 17, 2016 pregnancy outcome was successful with no abnormalities detected on ultrasound scanning during pregnancy or in the infant. Feb 01, 2009 prescribing anticoagulants to pregnant women can be difficult and stressful. Pdf anticoagulants in pregnancy andra james academia. Editorial management of anticoagulants during pregnancy. Know the properties of agents that can reverse the actions of heparin and the oral anticoagulants. Warfarin continued throughout pregnancy offers the best thromboembolic protection. Anticoagulants are drugs that treat blood clots, and help prevent blood clot formation in the veins and arteries. Physiological changes to coagulation during pregnancy pregnancy is associated with changes in haemostasis, including an increase in the majority of clotting factors, a decrease in the quantity of natural anticoagulants and a reduction in. Anticoagulant therapy during pregnancy is indicated for the treatment and prophylaxis of venous thromboembolic disease and for the prevention and treatment of systemic embolism associated with valvular heart disease andor. Pregnancy planning in chronically anticoagulated women 4.
Common side effects of these drugs are bruises, diarrhea, fever, intestinal gas, and headache. Anticoagulant therapy is complex and associated with substantial benefits and risks. Oral anticoagulants vka and noac guidelines for prescribing. Prevention of dvtpe during pregnancy and postpartum. The heparins are a group of anticoagulants that consist of unfractionated heparin, low molecular weight heparins, and heparinoids unfractionated heparin usually just called heparin needs to be given directly into the blood by intravenous iv injection, and inhibits thrombin and factor xa, factors necessary in the final stages of the blood clotting cascade. Anticoagulants acs are commonly used in pregnancy for prevention and management of thrombotic problems. Pregnancy is characterized by physical and physiologic changes that contribute to a tendency to clot.
Novel oral anticoagulants have emerged from clinical development. Unfractionated heparin, low molecular weight heparin, fondaparinux, and warfarin have been studied and employed extensively with direct thrombin inhibitors typically reserved for patients with complications or those requiring intervention. The heparinoid danaparoid orgaran is an lmwh, a combination of heparan, dermatan, and chondroitin sulfate. This guidance document addresses the use of doacs in women of childbearing potential, with particular focus on the preconceptual period, pregnancy and puerperium, and breast. In a study of the transfer of warfarin into breast milk, less than 25 ng warfarin was detected per milliliter 102. Be able to describe the biochemical mechanisms of action, therapeutic uses, contraindications and adverse effects of the specific anticoagulant and fibrinolytic agents listed above. These drugs are prescribed to patients to treat and prevent a variety of diseases and conditions dvt, pulmonary embolism, blood clot during atrial fibrillation. Pregnancy is associated with a hypercoagulable state. Venous thromboembolic vte complications are a leading cause of maternal mortality in the developed world.
Although pregnancy induces a state of hypercoagulability, the thromoboembolic risks during a normal pregnancy are minor. Fetal and neonatal effects of anticoagulants used in. Anticoagulant therapy during pregnancy is indicated for the treatment and prophylaxis of venous thromboembolic disease and for the prevention and treatment. These risks may be further increased in the presence of an acquired or inherited thrombophilia. In accordance with the northamerican guidelines american. Pregnancy is associated with changes in haemostasis, including an increase in the majority of clotting factors, a decrease in the quantity of natural anticoagulants and a reduction in. The use of heparin and oral anticoagulants during pregnancy is problematic because these drugs have the potential to produce adverse effects in the mother and fetus. Jun 30, 2017 the use of anticoagulants and thrombolytics in pregnancy is an important consideration. Get a printable copy pdf file of the complete article. Current guidelines advocate 2 anticoagulation strategies. Clinicians confront numerous practical issues in optimizing the use of anticoagulants to treat vte. Unfractionated heparin, low molecular weight heparin, fondaparinux, and warfarin have been studied and. Anticoagulant, thrombolytic, and antiplatelet drugs.
1129 391 117 1513 1443 599 919 399 1120 1029 200 115 450 672 484 660 288 388 790 1349 547 999 405 1342 369 792 1149 890 1411 850 526 1025